Literature DB >> 15356642

Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites.

B Streubel1, I Simonitsch-Klupp, L Müllauer, A Lamprecht, D Huber, R Siebert, M Stolte, F Trautinger, J Lukas, A Püspök, M Formanek, T Assanasen, H-K Müller-Hermelink, L Cerroni, M Raderer, A Chott.   

Abstract

Although several recurrent genetic aberrations are known to occur in MALT lymphoma, no comprehensive study on the most prevalent MALT lymphoma-associated genetic aberrations is available. We therefore screened 252 primary MALT lymphomas for translocations t(11;18)(q21;q21), t(14;18)(q32;q21), and t(1;14)(p22;q32), and trisomies 3 and 18. The above-listed translocations occurred mutually exclusively and were detected overall in 13.5, 10.8, and 1.6% of the cases; trisomy 3 and/or 18 occurred in 42.1%. The frequency at which the translocations occurred varied markedly with the primary site of disease. The t(11;18)(q21;q21) was mainly detected in pulmonary and gastric tumors, whereas the t(14;18)(q32;q21) was most commonly found in lesions of the ocular adnexa/orbit, skin, and salivary glands. Trisomies 3 and 18 each occurred most frequently in intestinal and salivary gland MALT lymphomas. Our results demonstrate that the three translocations and trisomies 3 and 18 occur at markedly variable frequencies in MALT lymphoma of different sites.

Entities:  

Mesh:

Year:  2004        PMID: 15356642     DOI: 10.1038/sj.leu.2403501

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  70 in total

1.  Translocation (5; 11) in a conjunctival MALT lymphoma.

Authors:  Cecilia G Clement; Venkateswara R Potluri; John Gonzales; You-Wen Qian
Journal:  Int J Clin Exp Pathol       Date:  2011-09-30

Review 2.  Lymphoproliferative lesions of the skin.

Authors:  L Cerroni
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

Review 3.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

4.  Marginal zone lymphoma of the lacrimal gland spreading to the lung and the bone marrow 11 years after first symptoms.

Authors:  Annette Zimpfer; Martin C Freund; Stephan Dirnhofer; Eberhard Gunsilius; Berthold Streubel; Andreas Chott; Alexandar Tzankov
Journal:  Virchows Arch       Date:  2005-11-17       Impact factor: 4.064

5.  Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications.

Authors:  Wee J Chng; Ellen D Remstein; Rafael Fonseca; P Leif Bergsagel; Julie A Vrana; Paul J Kurtin; Ahmet Dogan
Journal:  Blood       Date:  2008-10-30       Impact factor: 22.113

Review 6.  Primary extranodal marginal zone lymphoma of the endometrium: report of four cases and review of literature.

Authors:  Farnaz C Tahmasebi; Samar Roy; Jonathan E Kolitz; Filiz Sen; Jordan Laser; Xinmin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

7.  Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.

Authors:  M Raderer; B Streubel; S Wöhrer; M Häfner; A Chott
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

8.  T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.

Authors:  Xavier Sagaert; Brigitte Maes; Vera Vanhentenrijk; Mathijs Baens; Eric Van Cutsem; Gert De Hertogh; Karel Geboes; Thomas Tousseyn
Journal:  World J Gastrointest Oncol       Date:  2011-02-15

Review 9.  Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review.

Authors:  Aleksandra Petrovic; Aurélie Obéric; Alexandre Moulin; Mehrad Hamedani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-13       Impact factor: 3.117

Review 10.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.